The strongest stocks and groups. RS rating is O'Neil's: 12-month price change with the latest quarter counted double, ranked 1 to 99 against every US stock above $1 trading at least $1M a day.
42 stocks · 3,706 ranked · close of Fri, Nov 20
| Stock | 1M | RS | Ind RS | ADR | ||
|---|---|---|---|---|---|---|
| AXGNMedical Devices | +52.0% | 95 | 90 | +300%▲-400% | +26%▲+23% | 5.7% |
| GKOSMedical Devices | +34.3% | 98 | 96 | To profitSmaller loss | +58%▲+50% | 5.8% |
| KIDSMedical Devices | +28.4% | 97 | 95 | Smaller lossBigger loss | +19%▲+15% | 6.0% |
| DCTHMedical Devices | +27.4% | 97 | 95 | +750%▲0% | +71%▲+21% | 5.8% |
| PRCTMedical Devices | +23.3% | 59▲ | 42 | Bigger lossBigger loss | +18%+19% | 6.7% |
| TMDXMedical Devices | +18.3% | 37▼ | 27 | -30%-55% | +41%▲+21% | 6.1% |
| ENOVMedical Devices | +18.0% | 66 | 48 | To profitSmaller loss | +2%+3% | 5.9% |
| SIBNMedical Devices | +10.1% | 93 | 82 | Smaller lossSmaller loss | +15%+15% | 5.8% |
| ESTAMedical Devices | +8.8% | 54▲ | 37 | Smaller lossSmaller loss | +34%▲+32% | 6.4% |
| STAAMedical Devices | +7.7% | 64▼ | 46 | -39%To profit | -12%+111% | 5.4% |
| IARTMedical Devices | +7.5% | 52 | 36 | To profitTo profit | +2%▲+1% | 5.4% |
| MDLNMedical Devices | +6.2% | 54▼ | 38 | - | +10%+12% | 4.7% |
| TNDMMedical Devices | +1.8% | 36▼ | 26 | Smaller lossSmaller loss | +14%▲+6% | 8.1% |
| CDREMedical Devices | -0.0% | 34▼ | 24 | +37%▲-13% | +30%+32% | 4.4% |
| CBLLMedical Devices | -0.0% | 94 | 86 | Bigger lossBigger loss | +30%+33% | 5.7% |
| BAXMedical Devices | -1.0% | 84 | 67 | To profit+33% | +5%+5% | 4.3% |
| BRKRMedical Devices | -1.5% | 85 | 69 | Bigger loss-920% | +2%+5% | 6.0% |
| UFPTMedical Devices | -2.2% | 81▲ | 63 | +25%▲+21% | +12%+15% | 5.2% |
| NVSTMedical Devices | -4.4% | 47 | 32 | To profit+106% | +3%+7% | 4.2% |
| CNMDMedical Devices | -5.8% | 69▼ | 54 | +633%▲+12% | -1%+0% | 4.6% |
| ATRCMedical Devices | -6.6% | 96 | 91 | To profitTo profit | +15%▲+13% | 4.7% |
| RVTYMedical Devices | -7.7% | 94 | 84 | +40%▲+2% | +4%▲+1% | 4.5% |
| WRBYMedical Devices | -9.9% | 63▼ | 45 | -20%To profit | +10%▲+10% | 9.0% |
| PODDMedical Devices | -10.1% | 22▼ | 13 | +64%+328% | +19%+24% | 4.8% |
| ALMRMedical Devices | -10.9% | 56▼ | 39 | Smaller lossSmaller loss | +69%+82% | 8.3% |
| KMTSMedical Devices | -11.4% | 58▼ | 41 | Bigger loss | +60% | 6.5% |
| EYEMedical Devices | -11.4% | 32 | 23 | +500%▲+36% | +5%▲+3% | 6.6% |
| MMEDMedical Devices | -12.5% | 57▼ | 41 | Smaller loss | +17% | 5.3% |
| XRAYMedical Devices | -12.7% | 25 | 17 | Smaller lossTo profit | -8%-4% | 5.2% |
| PLSEMedical Devices | -13.5% | 98 | 97 | Bigger lossBigger loss | +359%▲First sales | 7.7% |
| HTFLMedical Devices | -15.8% | 95 | 87 | Smaller lossSmaller loss | +57%▲+48% | 6.9% |
| GMEDMedical Devices | -18.1% | 27 | 18 | +18%▲-26% | -1%+6% | 4.0% |
| STVNMedical Devices | -19.7% | 29▲ | 20 | - | - | 6.9% |
| BFLYMedical Devices | -20.7% | 91 | 76 | Smaller lossSmaller loss | +52%▲+40% | 8.1% |
| IRTCMedical Devices | -20.8% | 21▲ | 11 | Bigger lossSmaller loss | +15%+20% | 6.2% |
| INSPMedical Devices | -24.2% | 47▼ | 32 | -347%To profit | -8%-8% | 4.1% |
| AORTMedical Devices | -24.2% | 14 | 5 | -223%-1033% | +9%+11% | 6.0% |
| TXGMedical Devices | -25.7% | 98 | 98 | Smaller loss-150% | +1%▲-13% | 9.2% |
| ILMNMedical Devices | -28.4% | 89 | 73 | +46%▲-9% | +4%+9% | 5.7% |
| NVCRMedical Devices | -29.1% | 25 | 16 | Smaller lossSmaller loss | +16%▲+16% | 6.2% |
| BBNXMedical Devices | -30.9% | 28▼ | 19 | Bigger lossBigger loss | +30%+38% | 10.4% |
| ATECMedical Devices | -41.2% | 14 | 6 | Smaller lossSmaller loss | +13%+15% | 6.7% |
RS rating: 0.4 × 3-month + 0.2 × 6-month + 0.2 × 9-month + 0.2 × 12-month return, ranked 1 to 99. Stocks under a year old use the quarters they have. Ind RS ranks the same score among stocks in the same industry. Groups come from SEC SIC codes and need at least 3 stocks. A blue dot means the RS line (price against SPY) is at a 52-week high, a ringed one that it got there before the price. ADR is the 20-day average of high divided by low, minus 1. Updated after each close.
EPS and revenue growth come from the companies' own SEC filings (XBRL): the latest reported quarter against the same quarter a year earlier, with the quarter before under it and ▲ when growth sped up. EPS is diluted GAAP, not the adjusted figure in press releases. There is no percent off a loss or off zero sales; a move to profit or to first sales counts as 0% when sorting and filtering. Q4 is the fiscal year minus Q1 to Q3. Foreign filers (20-F) have no quarterly data. Filings through Sat, Nov 21.